Literature DB >> 7592181

In-vitro activity of oxazolidinones against Mycobacterium avium complex.

J Peters1, K L Kondo, R K Lee, C K Lin, C B Inderlied.   

Abstract

Options for treating disseminated Mycobacterium avium complex (MAC) disease have improved. However, efficacy is not always certain, resistance is common and rapidly bactericidal agents would improve efficacy and prevent resistance. Certain oxazolidinones were tested against MAC strains and inhibited growth at expected serum concentrations or lower. Activity correlated with hydrophobicity and one agent was bactericidal at concentrations two to five times greater than the MIC.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7592181     DOI： 10.1093/jac/35.5.675

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


  6 in total

1.  Disk diffusion test interpretive criteria and quality control recommendations for testing linezolid (U-100766) and eperezolid (U-100592) with commercially prepared reagents.

Authors:  D J Biedenbach; R N Jones
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

2.  A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins?

Authors:  G G Zhanel; C Shroeder; L Vercaigne; A S Gin; J Embil; D J Hoban
Journal:  Can J Infect Dis       Date:  2001-11

3.  In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.

Authors:  R N Jones; D M Johnson; M E Erwin
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 4.  Oxazolidinones: a review.

Authors:  D I Diekema; R N Jones
Journal:  Drugs       Date:  2000-01       Impact factor: 11.431

5.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

Review 6.  Linezolid Resistance in Staphylococci.

Authors:  Stefania Stefani; Dafne Bongiorno; Gino Mongelli; Floriana Campanile
Journal:  Pharmaceuticals (Basel)       Date:  2010-06-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.